

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.52944949 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.52944949 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.30751680 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.30751680 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.13261006 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.10002671 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.98351585 |
| 8 | tryptophan catabolic process (GO:0006569) | 4.76855730 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 4.76855730 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 4.76855730 |
| 11 | kynurenine metabolic process (GO:0070189) | 4.71846830 |
| 12 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.71298462 |
| 13 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.71298462 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.65575716 |
| 15 | urea cycle (GO:0000050) | 4.61005895 |
| 16 | urea metabolic process (GO:0019627) | 4.61005895 |
| 17 | glyoxylate metabolic process (GO:0046487) | 4.59414409 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.57809061 |
| 19 | protein carboxylation (GO:0018214) | 4.55608550 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.55608550 |
| 21 | tryptophan metabolic process (GO:0006568) | 4.46964947 |
| 22 | glycosphingolipid catabolic process (GO:0046479) | 4.44145809 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 4.43417649 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 4.41416060 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.41367306 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.35100651 |
| 27 | protein-lipid complex remodeling (GO:0034368) | 4.25164704 |
| 28 | macromolecular complex remodeling (GO:0034367) | 4.25164704 |
| 29 | plasma lipoprotein particle remodeling (GO:0034369) | 4.25164704 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.24223047 |
| 31 | lysine metabolic process (GO:0006553) | 4.22941233 |
| 32 | lysine catabolic process (GO:0006554) | 4.22941233 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.21958038 |
| 34 | plasma lipoprotein particle clearance (GO:0034381) | 4.19355884 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 4.03939514 |
| 36 | cysteine metabolic process (GO:0006534) | 4.03651530 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.03595961 |
| 38 | glycolipid catabolic process (GO:0019377) | 4.03447172 |
| 39 | killing of cells of other organism (GO:0031640) | 4.02417353 |
| 40 | disruption of cells of other organism (GO:0044364) | 4.02417353 |
| 41 | low-density lipoprotein particle remodeling (GO:0034374) | 3.93390936 |
| 42 | aldehyde catabolic process (GO:0046185) | 3.90978280 |
| 43 | bile acid metabolic process (GO:0008206) | 3.90933594 |
| 44 | homocysteine metabolic process (GO:0050667) | 3.87246411 |
| 45 | regulation of fibrinolysis (GO:0051917) | 3.83391098 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 3.81168794 |
| 47 | regulation of complement activation (GO:0030449) | 3.80740366 |
| 48 | reverse cholesterol transport (GO:0043691) | 3.80666246 |
| 49 | benzene-containing compound metabolic process (GO:0042537) | 3.76197278 |
| 50 | xenobiotic catabolic process (GO:0042178) | 3.75040326 |
| 51 | positive regulation of lipid catabolic process (GO:0050996) | 3.73962454 |
| 52 | phospholipid efflux (GO:0033700) | 3.72485504 |
| 53 | glucocorticoid biosynthetic process (GO:0006704) | 3.71077799 |
| 54 | triglyceride homeostasis (GO:0070328) | 3.67067280 |
| 55 | acylglycerol homeostasis (GO:0055090) | 3.67067280 |
| 56 | serine family amino acid catabolic process (GO:0009071) | 3.65839179 |
| 57 | aromatic amino acid family metabolic process (GO:0009072) | 3.64611336 |
| 58 | epoxygenase P450 pathway (GO:0019373) | 3.62565940 |
| 59 | cellular glucuronidation (GO:0052695) | 3.60956440 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 3.60658863 |
| 61 | reactive oxygen species biosynthetic process (GO:1903409) | 3.59573387 |
| 62 | low-density lipoprotein particle clearance (GO:0034383) | 3.59131161 |
| 63 | carnitine metabolic process (GO:0009437) | 3.57323004 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 3.56947444 |
| 65 | NADH metabolic process (GO:0006734) | 3.56199349 |
| 66 | 2-oxoglutarate metabolic process (GO:0006103) | 3.54742502 |
| 67 | oligosaccharide catabolic process (GO:0009313) | 3.53876399 |
| 68 | ceramide catabolic process (GO:0046514) | 3.53169977 |
| 69 | tyrosine metabolic process (GO:0006570) | 3.51716927 |
| 70 | uronic acid metabolic process (GO:0006063) | 3.51396446 |
| 71 | glucuronate metabolic process (GO:0019585) | 3.51396446 |
| 72 | valine metabolic process (GO:0006573) | 3.51200123 |
| 73 | regulation of macrophage chemotaxis (GO:0010758) | 3.48555953 |
| 74 | cholesterol efflux (GO:0033344) | 3.47682077 |
| 75 | phospholipid homeostasis (GO:0055091) | 3.47662062 |
| 76 | ethanol oxidation (GO:0006069) | 3.47446028 |
| 77 | fatty acid oxidation (GO:0019395) | 3.46694942 |
| 78 | negative regulation of sterol transport (GO:0032372) | 3.44383184 |
| 79 | negative regulation of cholesterol transport (GO:0032375) | 3.44383184 |
| 80 | drug catabolic process (GO:0042737) | 3.43380764 |
| 81 | lipid oxidation (GO:0034440) | 3.42251551 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 3.41264055 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.38058036 |
| 84 | plasma lipoprotein particle organization (GO:0071827) | 3.37509257 |
| 85 | acute-phase response (GO:0006953) | 3.37380064 |
| 86 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.36710643 |
| 87 | omega-hydroxylase P450 pathway (GO:0097267) | 3.34899445 |
| 88 | imidazole-containing compound metabolic process (GO:0052803) | 3.34667235 |
| 89 | cellular amino acid catabolic process (GO:0009063) | 3.33907817 |
| 90 | cofactor catabolic process (GO:0051187) | 3.32874826 |
| 91 | regulation of cholesterol storage (GO:0010885) | 3.32112621 |
| 92 | short-chain fatty acid metabolic process (GO:0046459) | 3.29336508 |
| 93 | fatty acid catabolic process (GO:0009062) | 3.28913802 |
| 94 | monocarboxylic acid catabolic process (GO:0072329) | 3.28493410 |
| 95 | regulation of mononuclear cell migration (GO:0071675) | 3.27802742 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.27320266 |
| 97 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.26575494 |
| 98 | amine catabolic process (GO:0009310) | 3.26547080 |
| 99 | cellular biogenic amine catabolic process (GO:0042402) | 3.26547080 |
| 100 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.26211446 |
| 101 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.25419854 |
| 102 | indolalkylamine metabolic process (GO:0006586) | 3.25331729 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.23826544 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.23826544 |
| 105 | Golgi transport vesicle coating (GO:0048200) | 3.23428485 |
| 106 | COPI coating of Golgi vesicle (GO:0048205) | 3.23428485 |
| 107 | response to nitrosative stress (GO:0051409) | 3.22921068 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.21855855 |
| 109 | coenzyme catabolic process (GO:0009109) | 3.20577218 |
| 110 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.19696129 |
| 111 | fibrinolysis (GO:0042730) | 3.19498603 |
| 112 | organic acid catabolic process (GO:0016054) | 3.19386105 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.19386105 |
| 114 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.18706237 |
| 115 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.18706237 |
| 116 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.18218908 |
| 117 | sterol homeostasis (GO:0055092) | 3.17470939 |
| 118 | oxaloacetate metabolic process (GO:0006107) | 3.16738963 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.12817862 |
| 120 | detection of molecule of bacterial origin (GO:0032490) | 3.09824016 |
| 121 | cellular response to cadmium ion (GO:0071276) | 3.09270540 |
| 122 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.06614622 |
| 123 | eosinophil chemotaxis (GO:0048245) | 2.99456488 |
| 124 | response to thyroid hormone (GO:0097066) | 2.97003911 |
| 125 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.93778564 |
| 126 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.93413475 |
| 127 | complement activation (GO:0006956) | 2.92417305 |
| 128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90341385 |
| 129 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.89172979 |
| 130 | glucocorticoid metabolic process (GO:0008211) | 2.88034278 |
| 131 | progesterone metabolic process (GO:0042448) | 2.87392898 |
| 132 | complement activation, classical pathway (GO:0006958) | 2.86811518 |
| 133 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.85687102 |
| 134 | tricarboxylic acid cycle (GO:0006099) | 2.83312816 |
| 135 | sphingolipid catabolic process (GO:0030149) | 2.83292193 |
| 136 | membrane lipid catabolic process (GO:0046466) | 2.83083101 |
| 137 | eosinophil migration (GO:0072677) | 2.82191016 |
| 138 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.78808010 |
| 139 | fructose metabolic process (GO:0006000) | 2.78019898 |
| 140 | monosaccharide biosynthetic process (GO:0046364) | 2.76600234 |
| 141 | regulation of vitamin metabolic process (GO:0030656) | 2.74798227 |
| 142 | cellular response to arsenic-containing substance (GO:0071243) | 2.73897733 |
| 143 | barbed-end actin filament capping (GO:0051016) | 2.71262397 |
| 144 | gluconeogenesis (GO:0006094) | 2.70005700 |
| 145 | regulation of cholesterol homeostasis (GO:2000188) | 2.68840733 |
| 146 | amino sugar catabolic process (GO:0046348) | 2.67715486 |
| 147 | protein activation cascade (GO:0072376) | 2.67068800 |
| 148 | protein-lipid complex assembly (GO:0065005) | 2.65594151 |
| 149 | pinocytosis (GO:0006907) | 2.62544325 |
| 150 | regulation of humoral immune response (GO:0002920) | 2.62270401 |
| 151 | exogenous drug catabolic process (GO:0042738) | 2.60063884 |
| 152 | positive regulation of lipid storage (GO:0010884) | 2.59137236 |
| 153 | adhesion of symbiont to host (GO:0044406) | 2.57861490 |
| 154 | response to peptidoglycan (GO:0032494) | 2.57776150 |
| 155 | hexose biosynthetic process (GO:0019319) | 2.57717228 |
| 156 | hyaluronan catabolic process (GO:0030214) | 2.53697899 |
| 157 | protein localization to endosome (GO:0036010) | 2.52668442 |
| 158 | androgen biosynthetic process (GO:0006702) | 2.52392216 |
| 159 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.51929303 |
| 160 | regulation of apoptotic cell clearance (GO:2000425) | 2.50411505 |
| 161 | positive regulation of humoral immune response (GO:0002922) | 2.48883341 |
| 162 | myeloid dendritic cell differentiation (GO:0043011) | 2.47969221 |
| 163 | detection of external biotic stimulus (GO:0098581) | 2.47238108 |
| 164 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.46444637 |
| 165 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.44443767 |
| 166 | vitamin D metabolic process (GO:0042359) | 2.44295956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.29779013 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.62666628 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.15751286 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.80572639 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.31774473 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.20410615 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.19514780 |
| 8 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.13108386 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.33388358 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.25066030 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.19323452 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.10831419 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.60199338 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53594944 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16320916 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15437896 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.11706430 |
| 18 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.03161635 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01039853 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95043139 |
| 21 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94275587 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85399407 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.85201242 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84832281 |
| 25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.81640255 |
| 26 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77553276 |
| 27 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.76723002 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76176448 |
| 29 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.75608128 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.71726213 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71704466 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69897579 |
| 33 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.66616003 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62641111 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55068392 |
| 36 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.52633137 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44998292 |
| 38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.41797309 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39348014 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.36155930 |
| 41 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34674669 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.26934209 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23240042 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16263831 |
| 45 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12823965 |
| 46 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.10602191 |
| 47 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10049980 |
| 48 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09910034 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08325240 |
| 50 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.05720032 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04277547 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01832622 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01779480 |
| 54 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99581255 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98959896 |
| 56 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98318440 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98028385 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97283859 |
| 59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96970262 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96346829 |
| 61 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96188221 |
| 62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93405920 |
| 63 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93153998 |
| 64 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92883495 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92882982 |
| 66 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92144427 |
| 67 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92054451 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91114054 |
| 69 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91037048 |
| 70 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90620759 |
| 71 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90290578 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89770986 |
| 73 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.86727609 |
| 74 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86643705 |
| 75 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.86082537 |
| 76 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85772250 |
| 77 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85113188 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84880949 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84134099 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84134099 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83716873 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82819379 |
| 83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.81963508 |
| 84 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81256965 |
| 85 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80184040 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80109864 |
| 87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79376522 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.77926395 |
| 89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76579820 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76092343 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75719211 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75273252 |
| 93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74932058 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74684857 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.74225292 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.73936536 |
| 97 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.73368414 |
| 98 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.73103620 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72554856 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72527469 |
| 101 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.71431351 |
| 102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.70847459 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70393096 |
| 104 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.70008172 |
| 105 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.70007137 |
| 106 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68387199 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68175454 |
| 108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.67835087 |
| 109 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.67612885 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67087890 |
| 111 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66481825 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65817867 |
| 113 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.65327221 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.65258562 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.64273986 |
| 116 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62106431 |
| 117 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62030291 |
| 118 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.61936189 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61896169 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.61738243 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.61322727 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.60910744 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.60910744 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60746486 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.60581157 |
| 126 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.60480884 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.60358927 |
| 128 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.60108436 |
| 129 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.60056781 |
| 130 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.60023120 |
| 131 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.59905746 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.59790795 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58178320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.40673637 |
| 2 | MP0005360_urolithiasis | 5.83977913 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.89577204 |
| 4 | MP0005365_abnormal_bile_salt | 4.77555380 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.66831093 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.21019931 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.14759795 |
| 8 | MP0009840_abnormal_foam_cell | 3.04197542 |
| 9 | MP0003252_abnormal_bile_duct | 2.85627884 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.72368210 |
| 11 | MP0005083_abnormal_biliary_tract | 2.70263910 |
| 12 | MP0003195_calcinosis | 2.45343796 |
| 13 | MP0005332_abnormal_amino_acid | 2.40205730 |
| 14 | MP0003186_abnormal_redox_activity | 2.10904136 |
| 15 | MP0000609_abnormal_liver_physiology | 2.01544790 |
| 16 | MP0003436_decreased_susceptibility_to | 2.00558509 |
| 17 | MP0005319_abnormal_enzyme/_coenzyme | 1.99493110 |
| 18 | MP0003724_increased_susceptibility_to | 1.98953124 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.95846174 |
| 20 | MP0003329_amyloid_beta_deposits | 1.93904000 |
| 21 | MP0001666_abnormal_nutrient_absorption | 1.92183646 |
| 22 | MP0004510_myositis | 1.89640989 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.78739021 |
| 24 | MP0009785_altered_susceptibility_to | 1.77116380 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.73862522 |
| 26 | MP0009764_decreased_sensitivity_to | 1.65645619 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63619302 |
| 28 | MP0001764_abnormal_homeostasis | 1.60103886 |
| 29 | MP0008260_abnormal_autophagy | 1.55775042 |
| 30 | MP0003303_peritoneal_inflammation | 1.50199392 |
| 31 | MP0000751_myopathy | 1.48549922 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.48225105 |
| 33 | MP0002419_abnormal_innate_immunity | 1.45886746 |
| 34 | MP0008469_abnormal_protein_level | 1.42926468 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.41925641 |
| 36 | MP0004233_abnormal_muscle_weight | 1.39915832 |
| 37 | MP0004130_abnormal_muscle_cell | 1.38738626 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.37901133 |
| 39 | MP0005451_abnormal_body_composition | 1.36000273 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.32871953 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.31728436 |
| 42 | MP0005670_abnormal_white_adipose | 1.31097920 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.27944244 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.27586813 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.27269179 |
| 46 | MP0009763_increased_sensitivity_to | 1.26354352 |
| 47 | MP0003950_abnormal_plasma_membrane | 1.25385878 |
| 48 | MP0005025_abnormal_response_to | 1.25213576 |
| 49 | MP0005165_increased_susceptibility_to | 1.24964700 |
| 50 | MP0008004_abnormal_stomach_pH | 1.23697464 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.23397538 |
| 52 | MP0000604_amyloidosis | 1.18477036 |
| 53 | MP0000598_abnormal_liver_morphology | 1.16434391 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.15953936 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.15051047 |
| 56 | MP0000343_altered_response_to | 1.14191842 |
| 57 | MP0006082_CNS_inflammation | 1.12607573 |
| 58 | MP0001853_heart_inflammation | 1.12108146 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.11096374 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.10555331 |
| 61 | MP0003075_altered_response_to | 1.10125564 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.08422241 |
| 63 | MP0005671_abnormal_response_to | 1.07776374 |
| 64 | MP0000747_muscle_weakness | 1.06500310 |
| 65 | MP0003448_altered_tumor_morphology | 1.05078126 |
| 66 | MP0000858_altered_metastatic_potential | 1.03841963 |
| 67 | MP0002971_abnormal_brown_adipose | 1.01086984 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.00284335 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.00104718 |
| 70 | MP0003646_muscle_fatigue | 1.00068457 |
| 71 | MP0001533_abnormal_skeleton_physiology | 0.98895133 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 0.98847150 |
| 73 | MP0001845_abnormal_inflammatory_respons | 0.98591151 |
| 74 | MP0000749_muscle_degeneration | 0.95597803 |
| 75 | MP0003868_abnormal_feces_composition | 0.94890664 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 0.94339853 |
| 77 | MP0005535_abnormal_body_temperature | 0.93731028 |
| 78 | MP0003828_pulmonary_edema | 0.93331071 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.92885364 |
| 80 | MP0009697_abnormal_copulation | 0.92859964 |
| 81 | MP0003690_abnormal_glial_cell | 0.91962490 |
| 82 | MP0002254_reproductive_system_inflammat | 0.91515668 |
| 83 | MP0009642_abnormal_blood_homeostasis | 0.89230976 |
| 84 | MP0002269_muscular_atrophy | 0.87900216 |
| 85 | MP0005164_abnormal_response_to | 0.87357581 |
| 86 | MP0005647_abnormal_sex_gland | 0.85001249 |
| 87 | MP0002420_abnormal_adaptive_immunity | 0.83997961 |
| 88 | MP0001819_abnormal_immune_cell | 0.83931678 |
| 89 | MP0001756_abnormal_urination | 0.83509234 |
| 90 | MP0003091_abnormal_cell_migration | 0.83504164 |
| 91 | MP0005166_decreased_susceptibility_to | 0.83029228 |
| 92 | MP0005000_abnormal_immune_tolerance | 0.82886082 |
| 93 | MP0005334_abnormal_fat_pad | 0.82741681 |
| 94 | MP0005023_abnormal_wound_healing | 0.82714415 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.81795229 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.79845172 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.79620414 |
| 98 | MP0004036_abnormal_muscle_relaxation | 0.78253071 |
| 99 | MP0000920_abnormal_myelination | 0.77460728 |
| 100 | MP0003011_delayed_dark_adaptation | 0.77088638 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.77086449 |
| 102 | MP0002972_abnormal_cardiac_muscle | 0.76490630 |
| 103 | MP0005266_abnormal_metabolism | 0.76457197 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.76293647 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.75932505 |
| 106 | MP0000750_abnormal_muscle_regeneration | 0.74803675 |
| 107 | MP0000249_abnormal_blood_vessel | 0.74516330 |
| 108 | MP0010368_abnormal_lymphatic_system | 0.72097147 |
| 109 | MP0009115_abnormal_fat_cell | 0.71553434 |
| 110 | MP0004087_abnormal_muscle_fiber | 0.71269915 |
| 111 | MP0003879_abnormal_hair_cell | 0.71248845 |
| 112 | MP0001661_extended_life_span | 0.71047100 |
| 113 | MP0001915_intracranial_hemorrhage | 0.69483611 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66219169 |
| 115 | MP0005408_hypopigmentation | 0.66001201 |
| 116 | MP0005387_immune_system_phenotype | 0.64300143 |
| 117 | MP0001790_abnormal_immune_system | 0.64300143 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.63885496 |
| 119 | MP0000685_abnormal_immune_system | 0.63656885 |
| 120 | MP0008873_increased_physiological_sensi | 0.63412403 |
| 121 | MP0002723_abnormal_immune_serum | 0.60937275 |
| 122 | MP0010155_abnormal_intestine_physiology | 0.60734311 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.60036300 |
| 124 | MP0004947_skin_inflammation | 0.59994007 |
| 125 | MP0005330_cardiomyopathy | 0.59904129 |
| 126 | MP0005448_abnormal_energy_balance | 0.58910842 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.57471869 |
| 128 | MP0003300_gastrointestinal_ulcer | 0.56148249 |
| 129 | MP0008874_decreased_physiological_sensi | 0.54578334 |
| 130 | MP0001800_abnormal_humoral_immune | 0.54009472 |
| 131 | MP0002166_altered_tumor_susceptibility | 0.53733997 |
| 132 | MP0004883_abnormal_blood_vessel | 0.52449513 |
| 133 | MP0005385_cardiovascular_system_phenoty | 0.51365376 |
| 134 | MP0001544_abnormal_cardiovascular_syste | 0.51365376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.44711683 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.36399801 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.15267118 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.14082416 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.14082416 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.14082416 |
| 7 | Xanthomatosis (HP:0000991) | 5.08249884 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 5.00137584 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.94727688 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.58266510 |
| 11 | Joint hemorrhage (HP:0005261) | 4.56458101 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.54598022 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.44256985 |
| 14 | Complement deficiency (HP:0004431) | 4.12944197 |
| 15 | Hyperammonemia (HP:0001987) | 4.06979551 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.90353586 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.88551715 |
| 18 | Hyperglycinuria (HP:0003108) | 3.87351543 |
| 19 | Ketosis (HP:0001946) | 3.82844739 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.80867271 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.69302683 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.65151644 |
| 23 | Epidermoid cyst (HP:0200040) | 3.59259650 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.56288041 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.56288041 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.49115130 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.44417488 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.43485084 |
| 29 | Hyperglycinemia (HP:0002154) | 3.34947285 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30371868 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.27178614 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.25910711 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.25057962 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.23314386 |
| 35 | Abnormality of complement system (HP:0005339) | 3.22428831 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.20325114 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 3.15843495 |
| 38 | Fat malabsorption (HP:0002630) | 3.11121552 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 3.08776839 |
| 40 | Cholecystitis (HP:0001082) | 3.08776839 |
| 41 | Loss of speech (HP:0002371) | 3.07450658 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.01636090 |
| 43 | Ketoacidosis (HP:0001993) | 3.01593032 |
| 44 | Myocardial infarction (HP:0001658) | 2.96183949 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.95798149 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.95798149 |
| 47 | Nausea (HP:0002018) | 2.92594022 |
| 48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.86026402 |
| 49 | Neurofibrillary tangles (HP:0002185) | 2.85565549 |
| 50 | Recurrent bacterial skin infections (HP:0005406) | 2.84857104 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.77045880 |
| 52 | Hyperbilirubinemia (HP:0002904) | 2.74922145 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.72858879 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.68877047 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.68854863 |
| 56 | Metabolic acidosis (HP:0001942) | 2.60428045 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.56718728 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52744690 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52744690 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52744690 |
| 61 | Mutism (HP:0002300) | 2.50938785 |
| 62 | Steatorrhea (HP:0002570) | 2.49016836 |
| 63 | Abnormality of glycolysis (HP:0004366) | 2.48466427 |
| 64 | Skin nodule (HP:0200036) | 2.48140250 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.47969324 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.47271808 |
| 67 | Conjugated hyperbilirubinemia (HP:0002908) | 2.46739456 |
| 68 | Distal lower limb muscle weakness (HP:0009053) | 2.46381269 |
| 69 | Mucopolysacchariduria (HP:0008155) | 2.45094815 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.45094815 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.43846187 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.39209548 |
| 73 | Hydroxyprolinuria (HP:0003080) | 2.39209548 |
| 74 | Lethargy (HP:0001254) | 2.39103843 |
| 75 | Axonal loss (HP:0003447) | 2.38941562 |
| 76 | Ragged-red muscle fibers (HP:0003200) | 2.38496209 |
| 77 | Glomerulonephritis (HP:0000099) | 2.35943966 |
| 78 | Amyloidosis (HP:0011034) | 2.32775304 |
| 79 | Apathy (HP:0000741) | 2.32665436 |
| 80 | Gout (HP:0001997) | 2.31948694 |
| 81 | Delayed CNS myelination (HP:0002188) | 2.31733291 |
| 82 | Esophageal varix (HP:0002040) | 2.31261930 |
| 83 | Cerebral inclusion bodies (HP:0100314) | 2.30207820 |
| 84 | Increased serum pyruvate (HP:0003542) | 2.29872277 |
| 85 | Exercise-induced myalgia (HP:0003738) | 2.29167317 |
| 86 | Pancreatitis (HP:0001733) | 2.28716960 |
| 87 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.27709543 |
| 88 | Cerebral edema (HP:0002181) | 2.27678158 |
| 89 | Gingival bleeding (HP:0000225) | 2.25629231 |
| 90 | Diminished motivation (HP:0000745) | 2.25548136 |
| 91 | Thrombophlebitis (HP:0004418) | 2.23526124 |
| 92 | Vascular calcification (HP:0004934) | 2.19991044 |
| 93 | Proximal tubulopathy (HP:0000114) | 2.18797464 |
| 94 | Upper motor neuron abnormality (HP:0002127) | 2.16484669 |
| 95 | Disinhibition (HP:0000734) | 2.16230831 |
| 96 | Autoimmune thrombocytopenia (HP:0001973) | 2.15375011 |
| 97 | Vomiting (HP:0002013) | 2.14362491 |
| 98 | Spastic diplegia (HP:0001264) | 2.12313943 |
| 99 | Cholelithiasis (HP:0001081) | 2.10681849 |
| 100 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.10564556 |
| 101 | Hemorrhage of the eye (HP:0011885) | 2.10557814 |
| 102 | Vertebral compression fractures (HP:0002953) | 2.10048860 |
| 103 | Increased serum ferritin (HP:0003281) | 2.09309409 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.08782544 |
| 105 | Purpura (HP:0000979) | 2.06603753 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 2.05771555 |
| 107 | Mitral stenosis (HP:0001718) | 2.05627052 |
| 108 | Abnormality of macrophages (HP:0004311) | 2.04981878 |
| 109 | EMG: myopathic abnormalities (HP:0003458) | 2.03323514 |
| 110 | Menorrhagia (HP:0000132) | 2.02724843 |
| 111 | Hepatosplenomegaly (HP:0001433) | 1.99944251 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.99708077 |
| 113 | Hypertriglyceridemia (HP:0002155) | 1.99427299 |
| 114 | Renal cortical cysts (HP:0000803) | 1.98841525 |
| 115 | Pulmonary embolism (HP:0002204) | 1.96864763 |
| 116 | Vacuolated lymphocytes (HP:0001922) | 1.96737434 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96549948 |
| 118 | Nephritis (HP:0000123) | 1.95538728 |
| 119 | Periodontitis (HP:0000704) | 1.95338040 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 1.95135780 |
| 121 | Increased connective tissue (HP:0009025) | 1.95045118 |
| 122 | Cardiovascular calcification (HP:0011915) | 1.94242820 |
| 123 | Hypokinesia (HP:0002375) | 1.93678156 |
| 124 | Nemaline bodies (HP:0003798) | 1.93544960 |
| 125 | Bone pain (HP:0002653) | 1.93020106 |
| 126 | Neonatal onset (HP:0003623) | 1.92756998 |
| 127 | Spontaneous abortion (HP:0005268) | 1.91647983 |
| 128 | Myoglobinuria (HP:0002913) | 1.91186277 |
| 129 | Muscle fiber inclusion bodies (HP:0100299) | 1.91041155 |
| 130 | Abnormal cartilage morphology (HP:0002763) | 1.90517235 |
| 131 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.90391175 |
| 132 | Recurrent skin infections (HP:0001581) | 1.89133890 |
| 133 | Malnutrition (HP:0004395) | 1.88643397 |
| 134 | Late onset (HP:0003584) | 1.87306239 |
| 135 | Gingivitis (HP:0000230) | 1.86837164 |
| 136 | Irritability (HP:0000737) | 1.85720416 |
| 137 | Hypoglycemic seizures (HP:0002173) | 1.83285995 |
| 138 | Elevated alkaline phosphatase (HP:0003155) | 1.81890646 |
| 139 | Nuclear cataract (HP:0100018) | 1.81263224 |
| 140 | Mediastinal lymphadenopathy (HP:0100721) | 1.80439185 |
| 141 | Rhabdomyolysis (HP:0003201) | 1.80339571 |
| 142 | Urticaria (HP:0001025) | 1.80252822 |
| 143 | Prolonged neonatal jaundice (HP:0006579) | 1.79609142 |
| 144 | Epistaxis (HP:0000421) | 1.78255400 |
| 145 | Progressive neurologic deterioration (HP:0002344) | 1.77447356 |
| 146 | Tetraparesis (HP:0002273) | 1.77400588 |
| 147 | Glycosuria (HP:0003076) | 1.76929168 |
| 148 | Exercise-induced muscle cramps (HP:0003710) | 1.75177418 |
| 149 | Orchitis (HP:0100796) | 1.74861983 |
| 150 | Pathologic fracture (HP:0002756) | 1.73487759 |
| 151 | Joint swelling (HP:0001386) | 1.70949403 |
| 152 | Interstitial pulmonary disease (HP:0006530) | 1.69050776 |
| 153 | Abnormality of the gallbladder (HP:0005264) | 1.69031416 |
| 154 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.66920140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.70293745 |
| 2 | ERN1 | 4.55450999 |
| 3 | NME2 | 3.14572498 |
| 4 | MAP3K14 | 2.74672928 |
| 5 | FGFR4 | 2.65711613 |
| 6 | TAOK3 | 2.57824641 |
| 7 | IRAK3 | 2.49312330 |
| 8 | SIK1 | 2.46877269 |
| 9 | TRIB3 | 2.45770821 |
| 10 | TBK1 | 2.37432694 |
| 11 | PRPF4B | 2.31518603 |
| 12 | ARAF | 2.30758023 |
| 13 | IRAK4 | 2.28380630 |
| 14 | PKN2 | 2.20582598 |
| 15 | TYK2 | 2.13154300 |
| 16 | MST1R | 2.06802113 |
| 17 | TAOK2 | 2.05888576 |
| 18 | PBK | 2.00171027 |
| 19 | ABL2 | 1.99280783 |
| 20 | TESK2 | 1.96315679 |
| 21 | BLK | 1.80385272 |
| 22 | RIPK4 | 1.79695733 |
| 23 | NEK9 | 1.76691422 |
| 24 | MAP2K3 | 1.75472042 |
| 25 | PAK4 | 1.72126697 |
| 26 | ERBB4 | 1.70014539 |
| 27 | EPHB1 | 1.67891393 |
| 28 | JAK1 | 1.62755037 |
| 29 | MOS | 1.62102168 |
| 30 | LIMK1 | 1.61743344 |
| 31 | FLT3 | 1.54545116 |
| 32 | MYLK | 1.50568546 |
| 33 | TIE1 | 1.49796572 |
| 34 | KSR2 | 1.44336772 |
| 35 | DDR2 | 1.40387840 |
| 36 | KDR | 1.38554150 |
| 37 | IKBKE | 1.37890342 |
| 38 | TTN | 1.36113920 |
| 39 | MAP3K3 | 1.32878352 |
| 40 | JAK2 | 1.32725983 |
| 41 | PDK4 | 1.28107511 |
| 42 | PDK3 | 1.28107511 |
| 43 | PIK3CG | 1.26831651 |
| 44 | INSRR | 1.23874943 |
| 45 | GRK7 | 1.23603757 |
| 46 | MAP4K1 | 1.23307035 |
| 47 | RIPK1 | 1.19259437 |
| 48 | EIF2AK3 | 1.18613144 |
| 49 | MAP3K9 | 1.15813018 |
| 50 | KIT | 1.15206151 |
| 51 | CSK | 1.13390613 |
| 52 | ICK | 1.12133188 |
| 53 | MAP3K12 | 1.07026409 |
| 54 | MAPK11 | 1.05135664 |
| 55 | PDK2 | 1.04965590 |
| 56 | MAP3K11 | 1.04632417 |
| 57 | PTK6 | 1.03204345 |
| 58 | DAPK2 | 1.02791771 |
| 59 | ZAP70 | 0.99428843 |
| 60 | PIM2 | 0.99107505 |
| 61 | EPHA3 | 0.94365873 |
| 62 | MAP3K8 | 0.92450495 |
| 63 | NEK1 | 0.88689438 |
| 64 | SMG1 | 0.88571119 |
| 65 | IKBKB | 0.88311597 |
| 66 | MAPK4 | 0.87916058 |
| 67 | MAP3K5 | 0.86253692 |
| 68 | STK4 | 0.84112069 |
| 69 | JAK3 | 0.80924323 |
| 70 | TEC | 0.80708519 |
| 71 | BUB1 | 0.80307003 |
| 72 | TAOK1 | 0.79924249 |
| 73 | EPHA2 | 0.79010849 |
| 74 | TGFBR2 | 0.78474653 |
| 75 | BTK | 0.78179223 |
| 76 | CDC42BPA | 0.76325087 |
| 77 | PRKAA2 | 0.74791822 |
| 78 | FGR | 0.74781089 |
| 79 | PDPK1 | 0.73880370 |
| 80 | GRK6 | 0.71713964 |
| 81 | CDK12 | 0.71578445 |
| 82 | TESK1 | 0.70565271 |
| 83 | STK24 | 0.67959027 |
| 84 | PINK1 | 0.67881768 |
| 85 | TSSK6 | 0.67494586 |
| 86 | FGFR3 | 0.67475690 |
| 87 | MAP2K4 | 0.67138880 |
| 88 | CAMK1D | 0.66764278 |
| 89 | SCYL2 | 0.65770038 |
| 90 | AKT2 | 0.65463100 |
| 91 | AKT3 | 0.63669120 |
| 92 | FRK | 0.63170763 |
| 93 | BMX | 0.63091073 |
| 94 | TRPM7 | 0.62329427 |
| 95 | RAF1 | 0.62039506 |
| 96 | LMTK2 | 0.60493911 |
| 97 | CSF1R | 0.60391684 |
| 98 | KSR1 | 0.59943790 |
| 99 | CSNK1G3 | 0.59396173 |
| 100 | SYK | 0.58935481 |
| 101 | PRKCD | 0.57835438 |
| 102 | LRRK2 | 0.56747592 |
| 103 | OBSCN | 0.56290821 |
| 104 | BRAF | 0.54740463 |
| 105 | RPS6KA6 | 0.53991811 |
| 106 | CHUK | 0.53984277 |
| 107 | MAPKAPK3 | 0.53901367 |
| 108 | IRAK1 | 0.53614837 |
| 109 | DMPK | 0.51937824 |
| 110 | CAMKK2 | 0.51284164 |
| 111 | CDK6 | 0.51045994 |
| 112 | RPS6KC1 | 0.50901715 |
| 113 | RPS6KL1 | 0.50901715 |
| 114 | LATS2 | 0.50614142 |
| 115 | PHKG2 | 0.50469764 |
| 116 | PHKG1 | 0.50469764 |
| 117 | HCK | 0.50394646 |
| 118 | SRPK1 | 0.50207561 |
| 119 | PRKACG | 0.49163286 |
| 120 | LYN | 0.48720525 |
| 121 | TXK | 0.48372252 |
| 122 | ABL1 | 0.48319158 |
| 123 | MST4 | 0.47671976 |
| 124 | CAMK2G | 0.45961963 |
| 125 | GSK3A | 0.44153486 |
| 126 | MAPK12 | 0.43853249 |
| 127 | MAP3K1 | 0.43806973 |
| 128 | PIM1 | 0.42801901 |
| 129 | PIK3CA | 0.42322688 |
| 130 | PDK1 | 0.41921262 |
| 131 | ALK | 0.41829600 |
| 132 | SIK3 | 0.41517449 |
| 133 | EGFR | 0.40977827 |
| 134 | DAPK1 | 0.40576486 |
| 135 | STK10 | 0.40035792 |
| 136 | DAPK3 | 0.38710003 |
| 137 | PRKCQ | 0.35857963 |
| 138 | MATK | 0.35713866 |
| 139 | CDK4 | 0.35281217 |
| 140 | ITK | 0.34501211 |
| 141 | PRKCZ | 0.33983912 |
| 142 | MAP3K13 | 0.33629842 |
| 143 | EIF2AK1 | 0.32792834 |
| 144 | PRKAA1 | 0.31813745 |
| 145 | RPS6KA2 | 0.31496453 |
| 146 | MAP3K7 | 0.30157122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.79626582 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23639844 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15097777 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.71910477 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.70202642 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69158779 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.52845511 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48495233 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47927341 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46446821 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37111858 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.33748643 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19459593 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.18008916 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16549780 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13157403 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07147297 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02321228 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96942620 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96836747 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95275628 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94807877 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84757014 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84564505 |
| 25 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.84291467 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80641863 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79822932 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61278479 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.60281909 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.51245501 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48889254 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46374736 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42435064 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38711322 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38219485 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36571200 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35285373 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31988679 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27647401 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20472571 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.19162131 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17642328 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17206981 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15690696 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.11973124 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.09901042 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09066862 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07022395 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05290182 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04646545 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03333279 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01876366 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01837836 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01227424 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97027004 |
| 56 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94363392 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.86319092 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84448808 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82328170 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79526055 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75913982 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75703620 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74064730 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69514829 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.69045976 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.67263927 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.64271053 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63356581 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62525289 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.60850231 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60460377 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57867413 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.57406627 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57329934 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54536812 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.53967464 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53744072 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.53416066 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52394010 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51311708 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49956232 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49747173 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49479482 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49285882 |
| 85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48271782 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45954543 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.45327874 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.44751959 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44405650 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44274300 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43138052 |
| 92 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.41289371 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.40596309 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40539961 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.35774425 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34171039 |
| 97 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33348507 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33304700 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32001367 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31984709 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30721581 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.30708942 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.29730434 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26001408 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.23698855 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.22769632 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20761622 |
| 108 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.20175737 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.19282395 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18795445 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.14964159 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14413423 |
| 113 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.14352437 |
| 114 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.13702763 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.13166340 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.12664664 |
| 117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.10269963 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.06297461 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.04928321 |
| 120 | Influenza A_Homo sapiens_hsa05164 | 0.04843945 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02936892 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.02832975 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02151133 |

